INDV · Indivior Pharmaceuticals, Inc. · Documents
$34.77
+0.90 (+2.66%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$4.00B
Shares
118.01M
Volume · Oct 20
1.93M
Avg daily vol (3M)
2.3M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 6-K | — | 2023-11-21 | 2023-11-20 | |
| 6-K | — | 2023-11-21 | 2023-11-20 | |
| 6-K | — | 2023-11-21 | — | |
| 6-K | — | 2023-11-21 | — | |
| 6-K | — | 2023-11-20 | — | |
| 6-K | — | 2023-11-20 | — | |
| 6-K | — | 2023-11-17 | — | |
| 6-K | — | 2023-11-16 | 2023-11-15 | |
| 6-K | — | 2023-11-16 | — | |
| 6-K | — | 2023-11-15 | — | |
| 6-K | — | 2023-11-13 | — | |
| 6-K | — | 2023-11-09 | 2023-09-30 | |
| 6-K | — | 2023-11-09 | — | |
| 6-K | — | 2023-11-02 | 2023-11-01 | |
| 6-K | — | 2023-10-26 | — | |
| 6-K | — | 2023-10-23 | — | |
| 6-K | — | 2023-10-13 | — | |
| 6-K | — | 2023-10-05 | — | |
| 6-K | — | 2023-09-29 | — | |
| 6-K | — | 2023-09-06 | — | |
| 6-K | — | 2023-08-21 | — | |
| 6-K | — | 2023-08-01 | — | |
| 6-K | — | 2023-07-27 | 2023-06-30 | |
| 6-K | — | 2023-07-26 | — | |
| 6-K | — | 2023-07-24 | — | |
| 6-K | — | 2023-07-10 | — | |
| 6-K | — | 2023-07-05 | — | |
| 6-K | — | 2023-06-30 | — | |
| 6-K | — | 2023-06-29 | — | |
| 6-K | — | 2023-06-27 | — | |
| 6-K | — | 2023-06-21 | — | |
| 6-K | — | 2023-06-16 | — | |
| 6-K | — | 2023-06-15 | — | |
| 6-K | — | 2023-06-14 | — | |
| 6-K | — | 2023-06-13 | — | |
| 6-K | — | 2023-06-12 | — |
Showing 351–386 of 386 filings
Key facts
CIK
1625297
CUSIP
45579U109
13F (30d)
31 filings
31 filers
Visit website
Investor relations